Disease Modelling and Drug Discovery

Infectious diseases remain a leading cause of deaths globally. Scientific models are utilized to comprehend the transmission of infections. The applications incorporate deciding ideal control approaches against new or creating infections, such as swine flu, Ebola, HIV, Zika, malaria and tuberculosis. It can be used to predict the impact of vaccination strategies against common infections such as rubella and measles.  The process of research or discover of a medicine for a disease is generally called as drug discovery. In contrast, patient specific drug discovery is a process of inventing a drug by considering the pros and cons and the anatomical conditions of the patient. The general medicine is discovered on the basis of the active ingredient from traditional remedies or serendipitous discovery. It can also be referred as personalized medicine, which separates patients into different categories.

 

    Related Conference of Disease Modelling and Drug Discovery

    October 21-22, 2019

    23rd European Biotechnology Congress

    Zurich, Switzerland
    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon | Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    | Lisbon, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    March 16-17, 2020 |

    12th World Congress and Expo on Cell & Stem Cell Research

    Chicago, Illinois, USA

    Disease Modelling and Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in